Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acelyrin Inc
(NQ:
SLRN
)
4.130
-0.090 (-2.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acelyrin Inc
< Previous
1
2
3
4
5
6
Next >
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
November 16, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
SLRN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 16, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm
November 15, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
NASDAQ:SLRN Investor Notice: Investigation over Potential Wrongdoing at Acelyrin, Inc.
October 31, 2023
San Diego, CA -- (SBWIRE) -- 10/31/2023 -- Certain directors of Acelyrin, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Acelyrin (SLRN) Q3 2023 Earnings Call Transcript
November 07, 2023
SLRN earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
November 07, 2023
From
ACELYRIN, INC.
Via
GlobeNewswire
ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer
November 06, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023
October 31, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Acelyrin, and Clorox and Encourages Investors to Contact the Firm
October 18, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 13, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 12, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 12, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NASDAQ:SLRN Shareholder Notice: Investigation over Possible Securities Laws Violations by Acelyrin, Inc.
October 06, 2023
San Diego, CA -- (SBWIRE) -- 10/06/2023 -- An investigation was announced over potential securities laws violations by Acelyrin, Inc in connection with certain financial statements.
Via
SBWire
ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development
October 03, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
September 30, 2023
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.
Via
InvestorPlace
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Acelyrin Stockholders and Encourages Investors to Contact the Firm
September 28, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Why Acelyrin Stock Plummeted 59% This Week
September 15, 2023
The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.
Via
The Motley Fool
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 13, 2023
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...
Via
Benzinga
Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism
September 12, 2023
Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe Hidradenitis Suppurativa (HS).
Via
Benzinga
Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher
September 12, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded up 0.11% to 34,702.55 while the NASDAQ fell 0.86% to 13,797.73....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
Via
Benzinga
Dow Turns Higher; Oracle Shares Tumble After Q1 Results
September 12, 2023
U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Tuesday. The Dow traded up 0.22% to 34,740.15 while the NASDAQ fell 0.55% to 13,841.02. The S&P 500, also fell,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday
September 12, 2023
A competitor's clinical trial stumble may be benefiting MoonLake.
Via
The Motley Fool
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 12, 2023
Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.
Via
Benzinga
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
September 12, 2023
Benzinga
Via
Benzinga
Is American Battery Technology Company (ABML) Stock Really Up 1,300%?
September 12, 2023
American Battery Technology Company (ABML) stock surprised investors Tuesday morning when it appeared to rocketing more than 1,300% higher.
Via
InvestorPlace
Dow Falls 75 Points; US Small Business Optimism Drops In August
September 12, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.22% to 34,587.58 while the NASDAQ fell 0.21%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Datasea (DTSS) Stock Down 39% Today?
September 12, 2023
Datasea (DTSS) stock is falling on Tuesday after the company announced a proposed public stock offering priced at 40 cents per share.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.